Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udo Holtick

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Leukemia Research|April 12, 2026
Retrospective, single-center analysis of second allogeneic stem cell transplantation versus non-transplant regimens for acute myeloid leukemia patients with relapse after first transplantationDaniel Schütte, Eva-Maria Call, Moritz Fürstenau, et al.
BMJ Open|August 31, 2023
Developing a supportive and palliative care intervention for patients with allogeneic stem cell transplantation: protocol of a multicentre mixed-methods study (allo-PaS)Anne Pralong, Marco Herling, Udo Holtick, et al.
European Journal of Haematology|April 13, 2017
Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantationKonstantin Höller, Lavinia Fabeni, Marco Herling, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 20, 2020
Detection of systemic immunosuppressants in autologous serum eye drops (ASED) in patients with severe chronic ocular graft versus host diseaseVolkan Tahmaz, Martin H J Wiesen, Uta Gehlsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cellsMuzlifah A Haniffa, Xiao-Nong Wang, Udo Holtick, et al.
ISRN Hematology|April 15, 2014
Pretransplant comorbidities maintain their impact on allogeneic stem cell transplantation outcome 5 years posttransplant: a retrospective study in a single german institutionJens M Chemnitz, Geothy Chakupurakal, Maya Bäßler, et al.
Annals of Hematology|October 20, 2021
Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospitalJorge Garcia Borrega, Jan-Michel Heger, Philipp Koehler, et al.
European Journal of Haematology|October 8, 2016
Regulatory B10 cells display an altered homoeostasis in acute graft-versus-host diseaseGeothy Chakupurakal, María Alejandra Garcia-Marquez, Alexander Shimabukuro-Vornhagen, et al.
European Journal of Haematology|July 2, 2015
FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remissionUdo Holtick, Alexander Shimabukuro-Vornhagen, Geothy Chakupurakal, et al.
Cancer Investigation|December 17, 2011
Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancerValentin Goede, Oliver Coutelle, Alexander Shimabukuro-Vornhagen, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Leukemia Research|April 12, 2026
Retrospective, single-center analysis of second allogeneic stem cell transplantation versus non-transplant regimens for acute myeloid leukemia patients with relapse after first transplantationDaniel Schütte, Eva-Maria Call, Moritz Fürstenau, et al.
BMJ Open|August 31, 2023
Developing a supportive and palliative care intervention for patients with allogeneic stem cell transplantation: protocol of a multicentre mixed-methods study (allo-PaS)Anne Pralong, Marco Herling, Udo Holtick, et al.
European Journal of Haematology|April 13, 2017
Dynamics of BKPyV reactivation and risk of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantationKonstantin Höller, Lavinia Fabeni, Marco Herling, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 20, 2020
Detection of systemic immunosuppressants in autologous serum eye drops (ASED) in patients with severe chronic ocular graft versus host diseaseVolkan Tahmaz, Martin H J Wiesen, Uta Gehlsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cellsMuzlifah A Haniffa, Xiao-Nong Wang, Udo Holtick, et al.
ISRN Hematology|April 15, 2014
Pretransplant comorbidities maintain their impact on allogeneic stem cell transplantation outcome 5 years posttransplant: a retrospective study in a single german institutionJens M Chemnitz, Geothy Chakupurakal, Maya Bäßler, et al.
Annals of Hematology|October 20, 2021
Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospitalJorge Garcia Borrega, Jan-Michel Heger, Philipp Koehler, et al.
European Journal of Haematology|October 8, 2016
Regulatory B10 cells display an altered homoeostasis in acute graft-versus-host diseaseGeothy Chakupurakal, María Alejandra Garcia-Marquez, Alexander Shimabukuro-Vornhagen, et al.
European Journal of Haematology|July 2, 2015
FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remissionUdo Holtick, Alexander Shimabukuro-Vornhagen, Geothy Chakupurakal, et al.
Cancer Investigation|December 17, 2011
Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancerValentin Goede, Oliver Coutelle, Alexander Shimabukuro-Vornhagen, et al.
Pageof 10